4-121816835-AAAG-A
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_005033.3(EXOSC9):c.1304_1306delAGA(p.Lys435del) variant causes a disruptive inframe deletion change. The variant allele was found at a frequency of 0.0000244 in 1,596,300 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000059 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000021 ( 0 hom. )
Consequence
EXOSC9
NM_005033.3 disruptive_inframe_deletion
NM_005033.3 disruptive_inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 4.00
Genes affected
EXOSC9 (HGNC:9137): (exosome component 9) This gene encodes a component of the human exosome, a exoribonuclease complex which processes and degrades RNA in the nucleus and cytoplasm. This component may play a role in mRNA degradation and the polymyositis/scleroderma autoantigen complex. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2011]
CCNA2 (HGNC:1578): (cyclin A2) The protein encoded by this gene belongs to the highly conserved cyclin family, whose members function as regulators of the cell cycle. This protein binds and activates cyclin-dependent kinase 2 and thus promotes transition through G1/S and G2/M. [provided by RefSeq, Aug 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EXOSC9 | NM_005033.3 | c.1304_1306delAGA | p.Lys435del | disruptive_inframe_deletion | 12/12 | ENST00000243498.10 | NP_005024.2 | |
CCNA2 | NM_001237.5 | c.*800_*802delCTT | 3_prime_UTR_variant | 8/8 | ENST00000274026.10 | NP_001228.2 | ||
EXOSC9 | NM_001034194.2 | c.1355_1357delAGA | p.Lys452del | disruptive_inframe_deletion | 13/13 | NP_001029366.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EXOSC9 | ENST00000243498.10 | c.1304_1306delAGA | p.Lys435del | disruptive_inframe_deletion | 12/12 | 1 | NM_005033.3 | ENSP00000243498.5 | ||
CCNA2 | ENST00000274026 | c.*800_*802delCTT | 3_prime_UTR_variant | 8/8 | 1 | NM_001237.5 | ENSP00000274026.5 |
Frequencies
GnomAD3 genomes AF: 0.0000591 AC: 9AN: 152242Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
9
AN:
152242
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000219 AC: 5AN: 228230Hom.: 0 AF XY: 0.0000162 AC XY: 2AN XY: 123622
GnomAD3 exomes
AF:
AC:
5
AN:
228230
Hom.:
AF XY:
AC XY:
2
AN XY:
123622
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000208 AC: 30AN: 1444058Hom.: 0 AF XY: 0.0000181 AC XY: 13AN XY: 717654
GnomAD4 exome
AF:
AC:
30
AN:
1444058
Hom.:
AF XY:
AC XY:
13
AN XY:
717654
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000591 AC: 9AN: 152242Hom.: 0 Cov.: 32 AF XY: 0.0000538 AC XY: 4AN XY: 74368
GnomAD4 genome
AF:
AC:
9
AN:
152242
Hom.:
Cov.:
32
AF XY:
AC XY:
4
AN XY:
74368
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 03, 2021 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. This variant has not been reported in the literature in individuals affected with EXOSC9-related conditions. This variant is present in population databases (rs745543259, ExAC 0.009%). This variant, c.1355_1357del, results in the deletion of 1 amino acid(s) of the EXOSC9 protein (p.Lys452del), but otherwise preserves the integrity of the reading frame. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at